CN1448497A - 减轻肝损伤或者不损伤肝脏的酒类饮料 - Google Patents
减轻肝损伤或者不损伤肝脏的酒类饮料 Download PDFInfo
- Publication number
- CN1448497A CN1448497A CN 02109374 CN02109374A CN1448497A CN 1448497 A CN1448497 A CN 1448497A CN 02109374 CN02109374 CN 02109374 CN 02109374 A CN02109374 A CN 02109374A CN 1448497 A CN1448497 A CN 1448497A
- Authority
- CN
- China
- Prior art keywords
- liver injury
- liver
- inebriant
- ethanol
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
减轻肝损伤或者不损伤肝脏的酒类饮料,是能够减轻或者消除酒精对肝脏损害的含酒精饮料。目前的酒类饮料引用后其中的乙醇主要是通过杆脏进行排解,如果一次饮用了过量的含酒饮料,就会给肝脏造成比较大的负担,多次过量会严重的损害肝脏。本产品的组成包括:水,每500ml水中含有容量比为0.5-300ml的乙醇,所述的水中含有2-1000mg的甘草酸或者甘草次酸或二者混合物。本产品用作各种含酒精饮料。
Description
技术领域:本发明涉及一种能够减轻或者消除酒精对肝脏损害的含酒精饮料。
背景技术:目前的酒类饮料引用后其中的乙醇主要是通过肝脏进行排解,如果一次饮用了过量的含酒饮料,就会给肝脏造成比较大的负担,多次过量会严重的损害肝脏。
发明内容:
本发明要解决的技术问题:提供一种减轻肝损伤或者不损伤肝脏的酒类饮料。
解决上述问题的技术方案:
减轻肝损伤或者不损伤肝脏的酒类饮料,其组成包括:水,每500ml水中含有容量比为0.5-300ml的乙醇,所述的水中含有2-1000mg的甘草酸或者甘草次酸或二者混合物。
上述的减轻肝损伤或者不损伤肝脏的酒类饮料,所述的甘草酸或者甘草次酸或二者混合物的含量为0.5-750mg。
上述的减轻肝损伤或者不损伤肝脏的酒类饮料,所述的乙醇包含在酿造或者勾兑的白酒、黄酒、果露酒、葡萄酒或者啤酒中,将上述的酒类折合其中的乙醇含量兑入。
上述的减轻肝损伤或者不损伤肝脏的酒类饮料,所述的甘草酸为甘草中的甘草酸二铵或者甘草酸单铵。
与现有技术相比的有益效果:
1.在酒类饮料中加入甘草酸或者甘草次酸或二者混合物后,酒中的乙醇以及白酒、黄酒、果露酒、葡萄酒或者啤酒中的有机质与甘草酸或者甘草次酸或二者混合物混合后,使饮用者明显感到饮酒后肝脏的负担减轻,甚至没有感觉。
2.经检验,其中形成的物质的性质及其结构类似于肾上腺皮质激素,具有明显的抗氧化、抗炎作用,特别是对肝膜具有明显的保护作用,其中甘草酸二铵的作用更为明显。
3.甘草本为止咳平喘类中药,通过酒中的乙醇作为溶剂,将甘草中的甘草酸二铵或者甘草酸单铵溶解出来并发生一定的生物反应,取得了保护人体内膜细胞的意想不到的效果,具有明显的技术上的进步。
4.使用甘草原株达到一定程度时,会引起的低血钾、高血钠、高血压和“满月脸”等毒副作用现象,经乙醇溶解和反应后,其中的有害成份被完全剔除或者受到抑制,消除了这些中毒现象。同时,该产品减轻或者在一定程度上消除了酒精对肝的毒性,保护了肝脏。
5.通过试验证明,本产品中甘草次酸等与乙醇结合后可以很好的与血管紧张素II的受体相结合,可以成为血管紧张素II的受体拮制剂。而该拮制剂是国际上多年来通过各类物质寻找非肽小分子的受体拮制剂的主攻目标,据目前资料记载和我们的试验,高血压病的治疗产生不可估量的重大作用。
下面 说明具体的实施方式:
实施例1.
减轻肝损伤或者不损伤肝脏的酒类饮料,其组成包括:水,每500ml水中含有容量比为0.5-300ml的乙醇,所述的水中含有2-1000mg的甘草酸或者甘草次酸或二者混合物。
实施例2:
上述的减轻肝损伤或者不损伤肝脏的酒类饮料,所述的甘草酸或者甘草次酸含量为0.5-750mg,或二者(3-7)∶(3-7)混合物。
实施例3:
上述的减轻肝损伤或者不损伤肝脏的酒类饮料,所述的乙醇包含在酿造或者勾兑的白酒、黄酒、果露酒、葡萄酒或者啤酒中,将上述的酒类折合其中的乙醇含量兑入。
上述的减轻肝损伤或者不损伤肝脏的酒类饮料,所述的甘草酸可以是含甘草酸二铵或者甘草酸单铵等类似结构和性能的组合物。
Claims (3)
1.一种减轻肝损伤或者不损伤肝脏的酒类饮料,其组成包括:水,每500ml水中含有容量比为0.5-300ml的乙醇,其特征是:所述的水中含有2-1000mg的甘草酸或者甘草次酸或二者混合物。
2.根据权利要求1所述的减轻肝损伤或者不损伤肝脏的酒类饮料,其特征是:所述的甘草酸或者甘草次酸或二者混合物的含量为0.5-750ml。
3.根据权利要求1或2所述的减轻肝损伤或者不损伤肝脏的酒类饮料,其特征是:所述的乙醇包含在酿造或者勾兑的白酒、黄酒、果露酒、葡萄酒或者啤酒中,将上述的酒类折合其中的乙醇含量兑入。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02109374 CN1448497A (zh) | 2002-03-28 | 2002-03-28 | 减轻肝损伤或者不损伤肝脏的酒类饮料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02109374 CN1448497A (zh) | 2002-03-28 | 2002-03-28 | 减轻肝损伤或者不损伤肝脏的酒类饮料 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1448497A true CN1448497A (zh) | 2003-10-15 |
Family
ID=28680387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02109374 Pending CN1448497A (zh) | 2002-03-28 | 2002-03-28 | 减轻肝损伤或者不损伤肝脏的酒类饮料 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1448497A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101033445B (zh) * | 2006-12-29 | 2010-05-12 | 天津津酒集团有限公司 | 护肝养生酒及其制备方法 |
CN103550236A (zh) * | 2013-10-26 | 2014-02-05 | 苏州天南星生物科技有限公司 | 复方牛磺酸制剂 |
EP2609922A4 (en) * | 2010-08-26 | 2014-04-02 | Shuguang Hospital Affiliated To Shanghai University Of Traditional Chinese Medicine | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CHRONIC ILL DISEASES AND USE THEREOF |
WO2014177989A2 (en) | 2013-04-29 | 2014-11-06 | Chigurupati Technologies Private Limited | Reduced toxicity in alcoholic beverages |
-
2002
- 2002-03-28 CN CN 02109374 patent/CN1448497A/zh active Pending
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101033445B (zh) * | 2006-12-29 | 2010-05-12 | 天津津酒集团有限公司 | 护肝养生酒及其制备方法 |
EP2609922A4 (en) * | 2010-08-26 | 2014-04-02 | Shuguang Hospital Affiliated To Shanghai University Of Traditional Chinese Medicine | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CHRONIC ILL DISEASES AND USE THEREOF |
WO2014177989A2 (en) | 2013-04-29 | 2014-11-06 | Chigurupati Technologies Private Limited | Reduced toxicity in alcoholic beverages |
WO2014177989A3 (en) * | 2013-04-29 | 2015-03-05 | Chigurupati Technologies Private Limited | Reduced toxicity in alcoholic beverages |
US9149491B2 (en) | 2013-04-29 | 2015-10-06 | Harsha Chigurupati | Reduced toxicity in alcoholic beverages |
CN105143428A (zh) * | 2013-04-29 | 2015-12-09 | 奇古鲁帕蒂技术私人有限公司 | 酒精饮料中降低的毒性 |
AU2014261082B2 (en) * | 2013-04-29 | 2016-06-16 | Harsha CHIGURUPATI | Reduced toxicity in alcoholic beverages |
US10039776B2 (en) | 2013-04-29 | 2018-08-07 | Harsha Chigurupati | Hepato-protective beverage composition |
EA030485B1 (ru) * | 2013-04-29 | 2018-08-31 | Харша Чигурупати | Спиртные напитки с пониженной гепатотоксичностью |
CN103550236A (zh) * | 2013-10-26 | 2014-02-05 | 苏州天南星生物科技有限公司 | 复方牛磺酸制剂 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9445623B2 (en) | Non-alcoholic wine beverage | |
Garcia‐Moreno et al. | High levels of melatonin generated during the brewing process | |
Hamada et al. | The effect of Eriobotrya japonica seed extract on oxidative stress in adriamycin-induced nephropathy in rats | |
Yayla et al. | Potential therapeutic effect of pomegranate seed oil on ovarian ischemia/reperfusion injury in rats | |
Lee et al. | Immunomodulatory effect of Hibiscus cannabinus extract on macrophage functions | |
Cui et al. | Antiarthritic effect of chitosan nanoparticle loaded with embelin against adjuvant‐induced arthritis in Wistar rats | |
Kassara et al. | Pectolytic enzyme reduces the concentration of colloidal particles in wine due to changes in polysaccharide structure and aggregation properties | |
Kumar et al. | Effects of lycopene and sodium valproate on pentylenetetrazol-induced kindling in mice | |
CN1448497A (zh) | 减轻肝损伤或者不损伤肝脏的酒类饮料 | |
US10071064B2 (en) | Tincture for infusing flavonoids and methods of use | |
Wang et al. | Fermented Cerasus humilis fruits protect against high‐fat diet induced hyperlipidemia which is associated with alteration of gut microbiota | |
US9474802B2 (en) | Compositions and methods to reduce hangover and reduce blood alcohol levels after alcohol consumption | |
Acosta et al. | Assessment of the antiurolithiatic and antioxidant properties of Ficus pseudopalma Blanco leaves (Moraceae) | |
US20170035827A1 (en) | Compositions and Methods to Reduce Hangover and Reduce Blood Alcohol Levels After Alcohol Consumption | |
Vidal-Carou et al. | Histamine and tyramine in natural sparkling wine, vermouth, cider, and vinegar | |
US9358216B2 (en) | Tincture for infusing resveratrol and methods of use | |
Yazdi et al. | Protective effects of cinnamic acid against hyperglycemia induced oxidative stress and inflammation in HepG2 cells | |
Hoseinynejad et al. | An Overview on Antioxidant and Anti-inflammatory Properties of Ellagic Acid in Renal Dysfunction | |
Ale et al. | Renoprotective effects of Cucumeropsis mannii seed oil on cisplatin-induced nephrotoxicity in Wistar rats | |
Caiazzo et al. | Red wine inhibits aggregation and increases ATP-diphosphohydrolase (CD39) activity of rat platelets in vitro | |
Soleimani et al. | Antidiabetic and Antioxidant Properties of Sea Urchin Echinometra mathaei from the Persian Gulf | |
US20110212198A1 (en) | Hangover relief by compositions comprising oral rehydration solution | |
Gulua et al. | Polyphenol content, antioxidant and anti-inflammatory activities of Georgian wine and green Tea | |
Ismail et al. | Aloe ferox leaf gel extracts attenuate redox imbalance in oxidative renal injury and stimulates glucose uptake, whilst inhibiting key enzymes linked to diabetes and obesity | |
CN114272260B (zh) | 一种海洋天然产物解酒保肝口服液、制备方法以及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |